Literature DB >> 4129310

A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone.

C D Marsden, J D Parkes, J E Rees.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4129310     DOI: 10.1016/s0140-6736(73)92729-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  L-dopa and carbidopa (sinemet) in the management of parkinsonism.

Authors:  E Critchley
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

2.  Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease.

Authors:  Lissa S Brod; Jason L Aldred; John G Nutt
Journal:  Mov Disord       Date:  2012-04-16       Impact factor: 10.338

3.  Letter: Alternatives to levodopa.

Authors:  M Hildick-Smith
Journal:  Br Med J       Date:  1976-06-05

4.  Sodium valproate in the treatment of levodopa-induced dyskinesia.

Authors:  P A Price; J D Parkes; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-08       Impact factor: 10.154

5.  Editorial: Dopa decarboxylase inhibitors.

Authors: 
Journal:  Br Med J       Date:  1974-11-02

6.  Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.

Authors:  D Tarsy; J D Parkes; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-04       Impact factor: 10.154

Review 7.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone?

Authors:  S G Ball; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

9.  Metabogenomics reveals four candidate regions involved in the pathophysiology of Equine Metabolic Syndrome.

Authors:  Laura Patterson Rosa; Martha F Mallicote; Maureen T Long; Samantha A Brooks
Journal:  Mol Cell Probes       Date:  2020-07-10       Impact factor: 2.365

10.  Reversible supranuclear ophthalmoplegia associated with Parkinsonism.

Authors:  R J Guiloff; R J George; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.